2-Butenedioic acid (2E)-, 1,4-diethyl ester
Common Name: |
2-Butenedioic acid (2E)-, 1,4-diethyl ester |
IUPAC Name: |
diethyl but-2-enedioate |
Molecular Formula: |
C8H12O4 |
SMILES: |
CCOC(=O)C=CC(=O)OCC |
Inchi: |
1S/C8H12O4/c1-3-11-7(9)5-6-8(10)12-4-2/h5-6H,3-4H2,1-2H3 |
Inchi Key: |
IEPRKVQEAMIZSS-UHFFFAOYSA-N |
Cas No: |
141-05-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
172.18 |
Mass (g/mol) |
172.074 |
Molar Refractivity |
42.67 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
6 |
Rings |
|
TPSA |
52.60 |
Hetero Atoms |
4 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
-10.00 to -8.00 |
Boiling Point (°C@760.00mm Hg) |
218.00 |
Vapor Pressure (mmHg@25.00 °C) |
1 |
Vapor Density (Air =1) |
5.93 |
Fraction Csp3 |
0.50 |
LogP |
0.669 |
iLOGP |
2.42 |
XLOGP3 |
0.94 |
WLOGP |
0.67 |
MLOGP |
0.84 |
ESOL Log S |
-1.10 |
ESOL Solubility (mg/ml) |
13.6 |
ESOL Solubility (mol/l) |
0.079 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.63 |
Ali Solubility (mg/ml) |
4.02 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.93 |
Silicos-IT Solubility (mg/ml) |
20.3 |
Silicos-IT Solubility (mol/l) |
0.12 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.68 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.263 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.508 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |